does medicaid cover glp-1 in ny The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs State-by-State Divide Over GLP-1 Medicaid
Description
A newer study, published in [29] , showed that 90% of patients using GLP-1RAs had slower gastrointestinal movement when tested with wireless motility capsules

The Ozempic lawsuit refers to a growing number of product liability claims filed against drug manufacturers Novo Nordisk and Eli Lilly alleging that GLP-1 medications caused severe injuries that were not adequately disclosed to patients or prescribing physicians
And are there rare, long-term side effects that we have yet to discover

Glucagonlike peptide 1(736) amides central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment

Behavioral weight control